- Home
- NCRA vs CMND Comparison
NCRA vs CMND Comparison
Compare NCRA & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCRA | CMND |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | Taiwan | Canada |
| Employees | 20 | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.6M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NCRA | CMND |
|---|---|---|
| Price | $1.43 | $1.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 249.2K |
| Earning Date | 04-15-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,627,944.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.06 | $0.07 |
| 52 Week High | $2.68 | $4.66 |
Technical Indicators
Market Signals| Indicator | NCRA | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 32.51 |
| Support Level | $0.86 | $0.13 |
| Resistance Level | $1.73 | $2.76 |
| Average True Range (ATR) | 0.22 | 0.16 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 11.29 | 0.00 |
Price Performance
Historical ComparisonAbout NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.